Traditional Chinese medicine preparation for treating retina phlebothrombosis

Abstract

The invention discloses a traditional Chinese medicine preparation for treating the retina phlebothrombosis. The traditional Chinese medicine preparation comprises bulk drugs by weight as follows: 20-30 g of rehmannia roots, 10-20 g of achyranthis radix, 10-20 g of periostracum cicadae, 10-20 g of equiseti herba, 10-20 g of dried tangerine peels, 10-20 g of kudzuvine roots, 10-20 g of roots of pseudo-ginseng, 10-20 g of dalbergiae odoriferae lignum, 10-20 g of gastrodia rhizome, 8-15 g of fleeceflower roots, 8-12 g of Japanese thistle herb, 8-12 g of Chinese taxillus herb, 8-12 g of eclipta, 8-12 g of himalayan teasel roots and 8-12 g of amur corktree bark. All the bulk drugs are excellently matched and play roles in tonifying livers and kidneys, harmonizing stomachs, invigorating spleens, relaxing tendons, activating collaterals, promoting blood circulation, removing blood stasis, cooling blood and improving eyesight, and the clinical application indicates that the traditional Chinese medicine preparation has the advantages that the preparation is accurate in curative effect, free of side effects, high in cure rate, good in patient compliance and the like when being used for treating the retina phlebothrombosis, so that the preparation is worthy of clinical promotion and application.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine and relates to a traditional Chinese medicine preparation for treating retinal vein thrombosis. Background technique [0002] Retinal vein thrombosis is a relatively common fundus disease that seriously damages visual function. Its formation is caused by local venous return obstruction. It can occur in the main trunk and branches, causing sudden loss of vision or extensive hemorrhage in the fundus, so it is one of the most typical syndromes of blood fatigue in ophthalmology. [0003] The incidence of this disease increases with age, the rate of blindness is 15.9%, and the rate of low vision is 23.1%. The general course of the disease is long, and the treatment is quite tricky. Western medicine mostly adopts comprehensive treatment, such as anticoagulation, dilating blood vessels, Lipid-lowering, blood vessel softening, absorption-promoting or photocoagulation treatments are often used,...

AI Technical Summary

Problems solved by technology

[0003] The incidence of this disease increases with age, the rate of blindness is 15.9%, and the rate of low vision is 23.1%. The general course of the disease is long, and the treatment is quite tricky. Western medicine mostly adopts comprehensive treatment, such as anticoagulation, dilating blood vessels, Lipid lowering, blood vessel softening, absorption promotion or photocoagulation, etc., but the curative effect is often unsatisfactory, and there are certain side effects, and the patient's compliance is poor

Images